An extension study to evaluate long term growth and development of hypertensive children 6-17 years of age previously treated with a substance called aliskiren - Trial 2011-004411-22

Name: Clinical Trial 2011-004411-22
Creator: Novartis Pharma Services AG
Keywords: Hypertension, clinical trial

Access comprehensive clinical trial information for 2011-004411-22 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharma Services AG and is currently status unknown. The study focuses on Hypertension.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2011-004411-22

Trial Details

EU Clinical Trials Register • 2011-004411-22

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

An extension study to evaluate long term growth and development of hypertensive children 6-17 years of age previously treated with a substance called aliskiren

Study Focus

Disease/Condition

Hypertension

Sponsor & Location

Primary Sponsor

Novartis Pharma Services AG

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

ICD-10 Classifications

Hypertensive diseases

Renovascular hypertension

Secondary hypertension

Other secondary hypertension

Hypertensive heart disease

Data Source

Registry

EU Clinical Trials Register

Trial ID

2011-004411-22

Type

Non-Device Trial